Home › Procedures › MRI Pelvis › Anthem BCBS (Carelon)
📋

Anthem BCBS (Carelon) — MRI Pelvis

This page shows prior authorization criteria extracted from Anthem BCBS (Carelon)'s published imaging guidelines. 79 matching coverage rules found for this procedure.

Coverage Rules from Anthem BCBS (Carelon) Policy

Abdominal and/or pelvic pain, undifferentiated

Indication Code: CARELON-ABDPEL-058

Acute Leukemia

Indication Code: CARELON-ONC-027

Adenomyosis

Indication Code: CARELON-ABDPEL-005

Adnexal mass

Indication Code: CARELON-ABDPEL-006

Anal Cancer

Indication Code: CARELON-ONC-008

Aneurysm of the abdominal aorta or iliac arteries

Indication Code: CARELON-VAS-029

Appendicitis

Indication Code: CARELON-ABDPEL-010

Avascular necrosis, bilateral hip

Indication Code: CARELON-ABDPEL-026

Axial spondyloarthropathy

Indication Code: CARELON-ABDPEL-027

Bladder and Urothelial Cancers

Indication Code: CARELON-ONC-009

Bladder or urethral diverticula

Indication Code: CARELON-ABDPEL-040

Bladder/Urothelial Cancers: Muscle Invasive

Indication Code: CARELON-ONC-011

Bladder/Urothelial Cancers: Non-muscle Invasive

Indication Code: CARELON-ONC-010

Bone Sarcoma

Indication Code: CARELON-ONC-042

Bowel obstruction

Indication Code: CARELON-ABDPEL-011

Brain and Spinal Cord Malignancy

Indication Code: CARELON-ONC-012

Breast Cancer

Indication Code: CARELON-ONC-013

Cancer screening, not otherwise specified

Indication Code: CARELON-ONC-007

Cancers of the Pleura, Thymus, Heart, and Mediastinum

Indication Code: CARELON-ONC-048

Cancers of Unknown Primary / Cancers Not Otherwise Specified

Indication Code: CARELON-ONC-014

Cervical Cancer

Indication Code: CARELON-ONC-015

Chronic lymphocytic leukemia or small lymphocytic lymphoma

Indication Code: CARELON-ONC-028

Colorectal Cancer

Indication Code: CARELON-ONC-016

Congenital and developmental conditions, not otherwise specified

Indication Code: CARELON-ABDPEL-001

Congenital or developmental vascular anomalies, not otherwise specified

Indication Code: CARELON-VAS-001

Constipation (Pediatric only)

Indication Code: CARELON-ABDPEL-012

Endometriosis

Indication Code: CARELON-ABDPEL-007

Gastric Cancer

Indication Code: CARELON-ONC-018

Gastrointestinal bleeding

Indication Code: CARELON-ABDPEL-015

Gastrointestinal stromal tumor (GIST)

Indication Code: CARELON-ONC-044

Head and Neck Cancer

Indication Code: CARELON-ONC-019

Hematuria (painless or undifferentiated)

Indication Code: CARELON-ABDPEL-041

Hepatocellular and Biliary Tract Cancers

Indication Code: CARELON-ONC-020

Hernia

Indication Code: CARELON-ABDPEL-052

Histiocytic Neoplasms

Indication Code: CARELON-ONC-021

Hydronephrosis

Indication Code: CARELON-ABDPEL-042

Infectious and inflammatory conditions including abscess– not otherwise specified

Indication Code: CARELON-ABDPEL-002

Inflammatory bowel disease (including Crohn’s disease and ulcerative colitis)

Indication Code: CARELON-ABDPEL-016

Kidney Cancer

Indication Code: CARELON-ONC-022

Lower extremity edema

Indication Code: CARELON-ABDPEL-060

Lung Cancer – Non-Small Cell

Indication Code: CARELON-ONC-023

Lung Cancer – Small Cell

Indication Code: CARELON-ONC-024

Lymphadenopathy

Indication Code: CARELON-ABDPEL-053

Melanoma

Indication Code: CARELON-ONC-030

Merkel Cell Carcinoma

Indication Code: CARELON-ONC-031

Multiple Myeloma

Indication Code: CARELON-ONC-032

Neuroendocrine Tumors

Indication Code: CARELON-ONC-033

Nonseminoma

Indication Code: CARELON-ONC-047

Obstetric indications

Indication Code: CARELON-ABDPEL-008

Osseous tumor

Indication Code: CARELON-ABDPEL-029

Osteomyelitis

Indication Code: CARELON-ABDPEL-031

Ovarian Cancer – All Variants

Indication Code: CARELON-ONC-036

Pancreatic Cancer

Indication Code: CARELON-ONC-037

Pancreatic mass, indeterminate cystic (including suspected IPMN/IPMT)

Indication Code: CARELON-ABDPEL-037

Pancreatic mass, indeterminate solid

Indication Code: CARELON-ABDPEL-036

Pancreatitis

Indication Code: CARELON-ABDPEL-038

Paraneoplastic Syndrome

Indication Code: CARELON-ONC-038

Pelvic floor disorders

Indication Code: CARELON-ABDPEL-054

Pelvic fracture

Indication Code: CARELON-ABDPEL-032

Penile, Vaginal, and Vulvar Cancers

Indication Code: CARELON-ONC-039

Perianal fistula/abscess (fistula in ano)

Indication Code: CARELON-ABDPEL-017

Polycystic kidney disease

Indication Code: CARELON-ABDPEL-044

Poorly-differentiated neuroendocrine tumor

Indication Code: CARELON-ONC-035

Prostate Cancer

Indication Code: CARELON-ONC-040

Renal artery stenosis/Renovascular hypertension

Indication Code: CARELON-ABDPEL-046

Retroperitoneal conditions

Indication Code: CARELON-ABDPEL-055

Sacroiliitis, not otherwise specified

Indication Code: CARELON-ABDPEL-033

Seminoma

Indication Code: CARELON-ONC-046

Septic arthritis

Indication Code: CARELON-ABDPEL-034

Soft Tissue Sarcoma

Indication Code: CARELON-ONC-043

Suspected or Known Metastases

Indication Code: CARELON-ONC-051

Thyroid Cancer

Indication Code: CARELON-ONC-049

Transplant-related imaging

Indication Code: CARELON-ABDPEL-056

Trauma, not otherwise specified

Indication Code: CARELON-ABDPEL-003

Tumor or neoplasm – not otherwise specified

Indication Code: CARELON-ABDPEL-004

Uterine Cancer

Indication Code: CARELON-ONC-050

Uterine leiomyomata (fibroids)

Indication Code: CARELON-ABDPEL-009

Vasculitis

Indication Code: CARELON-VAS-003

Well-differentiated neuroendocrine tumor

Indication Code: CARELON-ONC-034

How to Submit a Prior Authorization Request

Submit via: Anthem Provider Portal or Carelon Medical Benefits Management (formerly AIM) at 1-800-252-2021

📄 Required Documentation Checklist

  • Patient demographics and insurance information
  • Ordering provider NPI and contact information
  • Specific clinical indication with ICD-10 diagnosis code(s)
  • Relevant clinical history and physical exam findings
  • Results of prior conservative treatment (if applicable)
  • Prior imaging results relevant to the indication
  • Supporting lab or diagnostic results where applicable

⏱ Turnaround Times

Standard prior authorization requests are typically processed within 3–5 business days. Urgent/expedited requests may be processed within 24–72 hours when clinically necessary.

📣 Appeal Window

Most plans allow 30–60 days to file a first-level appeal. Expedited appeals for urgent cases are typically processed within 72 hours.

⚠ Common Denial Reasons

  • Insufficient clinical documentation to establish medical necessity
  • Clinical criteria not met per payer guidelines
  • Lack of documented prior conservative treatment
  • Missing required prior imaging as step therapy
  • Incorrect or unsupported ICD-10 diagnosis code pairing
  • Request submitted outside of authorization timeframe

⚠ MRI uses no ionizing radiation, which is an important clinical consideration when choosing between MRI and CT.

Clinical Approval Criteria

✓ Generally Approved When:

  • Reference prior ultrasound results
  • Fibroid mapping: document planned procedure (myomectomy, UFE) and that MRI will guide it
  • Prostate MRI: document PSA level, prior biopsy results, and clinical staging question
← Back to MRI Pelvis overview Search Coverage Database →
Disclaimer: Coverage criteria shown on this page are sourced from publicly available payer guidelines and are provided for informational and educational purposes only. Prior authorization requirements change frequently. Always verify current criteria directly with the payer or their delegated utilization management company before submitting an authorization request. This page does not constitute medical or legal advice.